BSE Prices delayed by 5 minutes ! Prices as on   Aug 08, 2025   

MARKETS

Company Info

INCOME STATEMENTS

Venmax Drugs & Pharmaceuticals Ltd.

You can view the income statements for the last 5 years.
GO

BSE

Aug 08
29.17 +0.47 (+ 1.64%)
Volume 18769
Prev. Close 28.70
Open Price 31.45
Today's Low / High
26.05
     
31.45
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
6.27
     
31.45
Venmax Drugs & Pharmaceuticals Ltd.is not traded in NSE
ISIN No INE154G01022 Market Cap. ( in Cr. ) 15.28 P/BV -23.15 Book Value ( ) -1.26
BSE Code 531015 52 Week High/Low ( ) 31/6 FV/ML 10/1 P/E(X) 0.00
NSE Code - Book Closure 21/09/2024 EPS ( ) 0.00 Div Yield (%) 0.00
( in Crs.)
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]0.810.000.000.000.17
Total Operating Revenues0.810.000.000.000.17
      
Other Income1.050.200.421.980.18
Total Revenue1.860.200.421.980.35
      
EXPENSES     
Cost Of Materials Consumed0.000.000.000.000.08
Purchase Of Stock-In Trade0.850.000.000.000.00
Changes In Inventories Of FG,WIP And Stock-In Trade-0.060.000.000.000.22
Employee Benefit Expenses0.040.020.030.010.06
Depreciation And Amortisation Expenses0.010.010.010.010.01
Other Expenses1.030.080.160.120.14
Total Expenses1.870.110.190.140.51
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-0.010.090.231.85-0.16
      
Profit/Loss Before Tax-0.010.090.231.85-0.16
      
Tax Expenses-Continued Operations     
Current Tax0.000.020.000.000.00
Total Tax Expenses0.000.020.000.000.00
Profit/Loss After Tax And Before ExtraOrdinary Items-0.010.060.231.85-0.16
      
Profit/Loss From Continuing Operations-0.010.060.231.85-0.16
      
Profit/Loss For The Period-0.010.060.231.85-0.16
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-0.020.120.433.52-0.31
Diluted EPS (Rs.)-0.020.120.433.52-0.31
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]0.81
Total Operating Revenues0.81
Other Income1.05
Total Revenue1.86
EXPENSES 
Cost Of Materials Consumed0.00
Purchase Of Stock-In Trade0.85
Changes In Inventories Of FG,WIP And Stock-In Trade-0.06
Employee Benefit Expenses0.04
Depreciation And Amortisation Expenses0.01
Other Expenses1.03
Total Expenses1.87
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-0.01
Profit/Loss Before Tax-0.01
Tax Expenses-Continued Operations 
Current Tax0.00
Total Tax Expenses0.00
Profit/Loss After Tax And Before ExtraOrdinary Items-0.01
Profit/Loss From Continuing Operations-0.01
Profit/Loss For The Period-0.01
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)-0.02
Diluted EPS (Rs.)-0.02